The Current Ratio as of December 2024 (TTM) for Axsome Therapeutics, Inc. (AXSM) is 2.44

According to Axsome Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.44. This represents a change of -16.88% compared to the average of 2.94 of the last 4 quarters.

Axsome Therapeutics, Inc. (AXSM) Historical Current Ratio (quarterly & annually)

How has AXSM Current Ratio performed in the past?

The mean historical Current Ratio of Axsome Therapeutics, Inc. over the last ten years is 5.78. The current 2.44 Current Ratio has changed 4.12% with respect to the historical average. Over the past ten years (40 quarters), AXSM's Current Ratio was at its highest in in the December 2015 quarter at 18.63. The Current Ratio was at its lowest in in the March 2015 quarter at 0.

Axsome Therapeutics, Inc. (AXSM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Axsome Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Axsome Therapeutics, Inc. (AXSM) Average Current Ratio

How has AXSM Current Ratio performed in the past?

The current Current Ratio of Axsome Therapeutics, Inc. (AXSM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Axsome Therapeutics, Inc. (AXSM) Current Ratio vs. Peers

How is AXSM’s Current Ratio compared to its peers?

Axsome Therapeutics, Inc.’s Current Ratio is greater than Incyte Corporation (1.87), less than ImmunoGen, Inc. (5.47), less than Sarepta Therapeutics, Inc. (3.84), greater than ACADIA Pharmaceuticals Inc. (2.29), less than Viking Therapeutics, Inc. (36.47), less than Madrigal Pharmaceuticals, Inc. (5.98), greater than Seres Therapeutics, Inc. (1.12), less than Intercept Pharmaceuticals, Inc. (4.22), less than TG Therapeutics, Inc. (4.59), less than Terns Pharmaceuticals, Inc. (32.99), greater than Hepion Pharmaceuticals, Inc. (1.30), less than Akero Therapeutics, Inc. (17.25), less than Reata Pharmaceuticals, Inc. (6.75), less than Day One Biopharmaceuticals, Inc. (14.62), less than Blueprint Medicines Corporation (3.32), less than PDS Biotechnology Corporation (2.84), less than Amylyx Pharmaceuticals, Inc. (4.55),

Build a custom stock screener for Axsome Therapeutics, Inc. (AXSM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Axsome Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Axsome Therapeutics, Inc. (AXSM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Axsome Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.